Harmonex, Inc. — Dothan, Alabama

Harmonex, Inc. is a clinical research site located in Dothan, Alabama, United States 36303.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Harmonex, Inc. has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Attention Deficit Hyperactivity Disorder, Depressive Disorder, Major, Attention-Deficit/Hyperactivity Disorder.

Sponsors: Ironshore Pharmaceuticals and Development, Inc, Naurex, Inc, an affiliate of Allergan plc, Purdue Pharma LP.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harmonex, Inc.?

Harmonex, Inc. has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harmonex, Inc. conducted?

Harmonex, Inc. has 5 clinical trials on record, with 1 currently active. Their work covers Attention Deficit Hyperactivity Disorder, Depressive Disorder, Major, Attention-Deficit/Hyperactivity Disorder.

Is Harmonex, Inc. accredited by Crixeo Health?

Harmonex, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harmonex, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.